Abstract 1957: Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer
Khyati N. Shah(Pfizer (United States)), Sourav Bandyopadhyay(University of California, San Francisco), Collin M. Blakely(City College of San Francisco), Roma Bhatt(University of California, San Francisco), Golzar Hemmati(University of California, San Francisco), Henry J. Haringsma(Clovis Oncology (United States)), Victor Olivas(University of California, San Francisco), Julia Rohrberg, Andrei Goga(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Andrew D. Simmons(Clovis Oncology (United States)), Trever G. Bivona(University of California, San Francisco), Thomas C. Harding(Genesys (United States)), Julia Rotow(University of California, San Francisco)
Cited by 0
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
|Proceedings of the National Academy of Sciences|2004|1.1k
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
|Cell|2008|959
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
Human host factors required for influenza virus replication
|Nature|2009|825